592493 Errata Notice-correcting the numbering scheme in subsections 6512.2 and 6512.7 in 17 DCMR § 6512.  

  • OFFICE OF DOCUMENTS AND ADMINISTRATIVE ISSUANCES

    AND

    DEPARTMENT OF HEALTH

    ERRATA NOTICE

    The Administrator of the Office of Documents and Administrative Issuances, pursuant to the authority set forth in section 309 of the District of Columbia Administrative Procedure Act, approved October 21, 1968 (82 Stat. 1203; D.C. Official Code § 2-559), and the Director of the Department of Health, pursuant to the authority set forth under § 302 (14) of the District of Columbia Health Occupation Revision Act of 1985, effective March 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1203.02 (14)) (Act), Mayor’s Order 98-140, dated August 20, 1998, and the Pharmacy Practice Amendment Act of 2008, effective March 20, 2009 (D.C. Law 17-0306; D.C. Official Code 3-1201.02(11), hereby gives notice of the following corrections to the text of the District of Columbia Municipal Regulations (DCMR) which was amended by a Notice of Final Rulemaking published in the D.C. Register and issued by the Department of Health on July 10, 2009 at 56 DCR 5566.

    The Notice of Final Rulemaking amended Chapter 65, “Pharmacists,” of Title 17 by adding a new Section 6512.  This Errata Notice corrects the incorrect numbering scheme in Subsections 6512.2 and 6512.7.  Subsection 6512.2 shall read as follows:

    6512.2             An applicant for certification to administer immunizations and vaccinations

    shall do the following:

    (a)                Submit a completed application and pay the required fee;

     

    (b)               Demonstrate to the satisfaction of the Board that he or she:

     

    (1)        Is licensed in good standing under the Act to practice pharmacy;

    (2)               Possesses an active certification in cardiopulmonary resuscitation for health care providers; and

     

    (3)               Has successfully completed an ACPE approved course approved by the Board of Pharmacy which:

     

    (A)             Is evidence-based;

     

    (B)              Includes study material;

     

    (C)              Includes hands-on training in techniques for administering immunizations or vaccines;

     

    (D)             Requires testing with a passing score;

     

    (E)              Meets current Center for Disease Control and Prevention training guidelines; and

     

    (F)               Provides a minimum of twenty (20) hours of instruction and hands-on training in:

     

    (i)                 Basic immunology and vaccine protection;

     

    (ii)               Vaccine-preventable diseases;

     

    (iii)             Vaccine storage and management;

     

    (iv)             Informed consent;

     

    (v)               Physiology and techniques for vaccine administration;

     

    (vi)             Pre and post-vaccine assessment and counseling;

     

    (vii)           Immunization record management; and

     

    (viii)         Identification, appropriate response, documentation, and reporting of adverse events.

     

    Subsection 6512.7 shall read as follows:

    6512.7             The written protocol shall contain, at a minimum, the following:

    (a)        A statement identifying the individual physician authorized to prescribe drugs and responsible for the delegation of administration of immunizations or vaccinations;

    (b)        A statement identifying the individual pharmacist(s) authorized to administer immunizations or vaccinations as delegated by the physician;

    (c)        A statement identifying the patient or groups of patients to receive the authorized immunization or vaccination; which shall be limited to:

    (1)        Patients who are currently under the individual physician’s care or with whom the physician has provided medical treatment or care within the twelve months prior to the date of the written protocol;

    (2)        Patients who are currently under the practice’s care or with whom a physician within the practice has provided medical treatment or care within the twelve months prior to the date of the written protocol;

    (3)        Residents of a health care, residential services, or assisted living facility, when the medical director of such facility is the physician making the delegation;

    (4)        District resident populations identified by the Director of the Department of Health as part of a public health services program, when the Director, or his or her designee, is the physician making the delegation; and

    (5)        Inmates of the District of Columbia jail, when the medical director for the facility is the physician making the delegation.

    (d)               A statement identifying the location(s) at which the pharmacist may  administer immunizations or vaccinations which shall not include where a patient resides, except for a licensed nursing home, residential care facility, assisted living center, the District of Columbia jail, or a hospital;

     

    (e)                A statement identifying the immunizations and vaccinations and emergency anaphylactic reaction treatment that may be administered by the pharmacist;

     

    (f)                A statement identifying the activities the pharmacist shall follow in the course of administering immunizations and vaccinations, including procedures to follow in the case of reactions following administration; and

     

    (g)               A statement that describes the content of, and the appropriate mechanisms for the pharmacist to report the administration of immunizations and vaccinations to the physician issuing the written protocol within the time frames specified in the protocol; which shall include providing the physician with a copy of the following records:

     

    (1)        The name, address, gender, allergies and date of birth of the individual receiving the immunization or vaccination;

    (2)        The date of administration

    (3)        The route and site of the immunization or vaccination;

    (4)        The name, dose, manufacturer’s lot number, and expiration date of the vaccine;

    (5)        The name of the pharmacist administering the immunization or vaccination;

    (6)        Any adverse events encountered.

    The text of Chapter 65 of Title 17 of the District of Columbia Municipal Regulations is corrected in accordance with the intended text of the Rulemaking.

    Any questions or comments regarding this notice shall be addressed by mail to Administrator, Office of Documents and Administrative Issuances, 441 4th Street, N.W., Suite 520 South, Washington, D.C. 20001, or via telephone at (202) 727-5090.

Document Information

Rules:
17-6512